Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127958) titled 'A study on the role of TNFSF9 in glioblastoma' on July 10.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Hangzhou First People's Hospital
Condition:
Glioblastoma, GBM
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-10
Target Sample Size: Glioblastoma tissue sample group:5;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=332256
Published by HT Digital Content Services with permission from Health Daily Digest....